U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777445) titled 'Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)' on Aug. 17.

Brief Summary: The investigators aim to study the effect of liquid oxygen therapy (4l/min, nasal) )in Swiss residents with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Pulmonary Vascular Disease Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pulmonary Arterial Hypertension (PAH)

Intervention: OTHER: 6-minute walk distance (6MWD) test on ambient ...